CMS TAVR Coverage Update Benefits Edwards, Medtronic, Abbott

The U.S. Centers for Medicare and Medicaid Services (CMS) has put forward a proposal to revise its National Coverage Determination (NCD) for transcatheter aortic valve replacement (TAVR) therapy, a move that could broaden patient access and reduce procedural barriers across the sector. The agency began its review in December 2025 after accepting a request from […]

The post CMS TAVR Coverage Update Benefits Edwards, Medtronic, Abbott first appeared on HHM Global | B2B Online Platform & Magazine.